Production (Stage)
Devonian Health Group Inc.
DVHGF
$0.18
$0.036225.17%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.55M | 21.37M | 16.91M | 13.43M | 7.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.55M | 21.37M | 16.91M | 13.43M | 7.56M |
| Cost of Revenue | 14.85M | 14.42M | 11.16M | 8.68M | 4.97M |
| Gross Profit | 7.70M | 6.95M | 5.74M | 4.75M | 2.59M |
| SG&A Expenses | 5.55M | 5.21M | 5.21M | 4.36M | 3.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 89.60K | 89.60K | 89.90K | 89.60K | 89.20K |
| Total Operating Expenses | 21.93M | 20.94M | 17.49M | 14.08M | 9.69M |
| Operating Income | 616.30K | 427.80K | -589.50K | -644.50K | -2.12M |
| Income Before Tax | -2.89M | 216.90K | -826.80K | -913.80K | -2.35M |
| Income Tax Expenses | 307.50K | 507.50K | 200.00K | 200.00K | 200.00K |
| Earnings from Continuing Operations | -3.19 | -0.29 | -1.03 | -1.11 | -2.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.19M | -290.70K | -1.03M | -1.11M | -2.55M |
| EBIT | 616.30K | 427.80K | -589.50K | -644.50K | -2.12M |
| EBITDA | 1.04M | 866.10K | -135.00K | -176.90K | -1.83M |
| EPS Basic | -0.02 | 0.00 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.02 | 0.00 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 592.90M | 592.22M | 590.34M | 588.08M | 587.24M |
| Average Diluted Shares Outstanding | 604.79M | 605.97M | 604.09M | 601.84M | 600.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |